United Therapeutics Corp (NASDAQ:UTHR)
CAPS Rating:
A biotechnology company focused on the development and commercialization of innovative therapeutic products for patients with chronic and life-threatening cardiovascular, cancer and infectious diseases.
RSS Headlines
Fool UK
Recs
http://seekingalpha.com/article/133869-fda-clinical-trial-updates-watson-pharma-united-therapeutics-auxilium-dendreon?source=feed